Supplementary Figure 3.
Cumulative survival of 209 patients with neuroblastoma. The Kaplan-Meier curves show the probability of overall survival (OS) with respect to A) the number of copies of MYCN found by fluorescence in situ hybridization (5-year overall survival rate ± SEM: MYCN amplified, 32±10 % vs not amplified, 82±3 %, P <.001); B) tumor stage, categorized as favorable (INSS stages 1, 2A/2B or 4S) or unfavorable (INSS stages 3 or 4) (5-year overall survival rate ± SEM: favorable stage, 96±2 % vs unfavorable stage, 50±6 %, P <.001); and C) the patient's age at diagnosis (5-year overall survival rate ± SEM: age < 1 year, 93± 3 % vs age > 1 year, 62±5 %, P<.001). P values were determined by the log-rank test. Tick marks indicate the length of follow-up of individual patients who survived. The median follow-up after diagnosis among the surviving patients was 55 months (range, 0-196) . At 0, 3 and 6 years from diagnosis, the number of patients at risk of death are shown. SEM = standard error of the mean. (2)-C cells to SMARTpool siRNA duplex 1 (ABCC4.1), independent siRNA duplex 5 (ABCC4.5) or to control siRNA. B) Enhanced neurite extension in SH-SY5Y cells upon depletion of ABCC4. C) 3 H-thymidine incorporation was reduced in SH-SY5Y cells depleted of ABCC4. D) Clonogenic capacity upon depletion of ABCC4 was assayed after 12 days. Means displayed in all panels are derived from at least 3 independent experiments. In panels B and D, P values were derived from oneway analysis of variance followed by two-sided t test vs control, while one-sample t test was used in panel C (H 0 , µ=100%). ABCC4 = ATP-binding cassette, sub-family C, member 4; siRNA = short interfering RNA.
Supplementary Figure 7.
Prognostic significance of ABCC3 and ABCC4 gene expression in neuroblastoma. A) Expression of ABCC4 predicts cumulative event-free survival (EFS) in 209 patients with neuroblastoma (relative hazard = 4.7, 95% CI = 2.5 to 8.9, P < .001). Similar associations between high ABCC4 gene expression and increasingly poor outcome were also observed in subgroups of patients B) with Stage 3 or 4 disease (five-year event-free survival rate ± SE: high ABCC4, 21±22 % vs low ABCC4, 54±12 %, P < .001) or C) whose tumors lacked MYCN amplification (five-year eventfree survival rate ± SE: high ABCC4, 53±34 % vs low ABCC4, P=.02). D) Expression of ABCC3 predicts cumulative event-free survival in 209 patients with neuroblastoma (relative hazard = 2.4, 95% CI = 1.4 to 4.2, P=.001). Similar associations between low ABCC3 gene expression and increasingly poor outcome were also observed in subgroups of patients E) with Stage 3 or 4 disease (five-year event-free survival rate ± SE: low ABCC3, 34±17 % vs high ABCC3, 57±13 %, P = .03) or F) whose tumors lacked MYCN amplification (five-year event-free survival rate ± SE: low ABCC3, 63±14 % vs high ABCC3, 84±7 %, P = .0016). At 0, 3 and 6 years from diagnosis, the number of patients at risk of relapse are shown. SE = standard error; MYCN = v-myc myelocytomatosis viral related oncogene, neuroblastoma derived. ABCC= ATP-binding cassette, sub-family C. Supplementary Figure 8 . Impact of stable ABCC3 expression in BE(2)-C cells. A) Western blot analysis of ABCC3 protein expression following stable retroviral transduction and mass-culturing of BE(2)-C cells with either empty vector or pCMV-ABCC3 (kindly provided by P. Borst, Netherlands Cancer Institute, (1)). B) Representative images of wound closure assay. Scale bar = 100m. C) Quantification depicting impaired motility of BE(2)-C cells stably overexpressing ABCC3. D) Clonogenic capacity was significantly reduced in BE(2)-C cells overexpressing ABCC3. E) Effect of ABCC3 overexpression on cell proliferation in BE(2)-C cells was measured by 5-bromo-2-deoxyuridine (BrdU) incorporation. One-way analysis of variance followed by two-sided t tests vs control were used to generate P values for wound closure and colony forming assays whereas onesample t test was used for BrdU incorporation (H 0 , µ=100%). In all panels means are derived from 3 replicate experiments and error bars represent standard error of the mean. ABCC3 = ATP-binding cassette, sub-family C, member 3. 
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